Liam Ratcliffe Insider Trading $COGT Cogent Biosciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Liam Ratcliffe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Liam Ratcliffe. Liam Ratcliffe is Director in ARRAY BIOPHARMA INC ($ARRY) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in Unum Therapeutics Inc. ($UMRX) and Director in Deciphera Pharmaceuticals, Inc. ($DCPH) and Director in ARVINAS INC. ($ARVN) and Director in Aptinyx Inc. ($APTX).
Liam Ratcliffe in Cogent Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Liam Ratcliffe: Director
Holdings: 622,772 shares
Latest Transaction: Jun 18 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Liam Ratcliffe in Cogent Biosciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, ARRY, ARVN, COGT, DCPH, EDGE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 2.43 | 7,881 | 19,151 | 7,881 | |
| Apr 03 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 4.40 | 4,829 | 21,248 | 4,829 | |
| Jan 04 2019 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 4.47 | 4,860 | 21,724 | 4,860 | |
| Oct 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 10.37 | 2,111 | 21,891 | 2,111 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | A | 14.57 | 1,504 | 21,913 | 1,504 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 977,836 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Option Exercise | C | 0.00 | 977,835 | 0 | 0 | |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Buy | P | 12.00 | 275,000 | 3,300,000 | 897,773 | 622.8 K to 897.8 K (+44.16 %) |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Buy | P | 12.00 | 275,000 | 3,300,000 | 897,772 | 622.8 K to 897.8 K (+44.16 %) |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 622,773 | 0 | 622,773 | 0 to 622.8 K |
| Apr 03 2018 | UMRX | Unum Therapeutics ... | Ratcliffe Liam | Director | Buy | C | 0.00 | 622,772 | 0 | 622,772 | 0 to 622.8 K |
Page: 1